BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fell DB, Dimanlig-Cruz S, Regan AK, Håberg SE, Gravel CA, Oakley L, Alton GD, Török E, Dhinsa T, Shah PS, Wilson K, Sprague AE, El-Chaâr D, Walker MC, Barrett J, Okun N, Buchan SA, Kwong JC, Wilson SE, Dunn SI, MacDonald SE, Dougan SD. Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study. BMJ 2022;378:e071416. [PMID: 35977737 DOI: 10.1136/bmj-2022-071416] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Fell DB, Török E, Sprague AE, Regan AK, Dhinsa T, Alton GD, Dimanlig-Cruz S, MacDonald SE, Buchan SA, Kwong JC, Wilson SE, Håberg SE, Gravel CA, Wilson K, Dunn SI, Shah PS, El-Chaâr D, Barrett J, Walker MC, Okun N, Dougan SD. Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study. Vaccine 2023;41:1716-25. [PMID: 36759282 DOI: 10.1016/j.vaccine.2023.01.073] [Reference Citation Analysis]
2 Wyszynski DF, Bhattacharya M, Martínez-Pérez O, Scialli AR, Tassinari M, Bar-Zeev N, Renz C, Hernández-Díaz S. The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations. Drug Saf 2023;46:297-308. [PMID: 36682012 DOI: 10.1007/s40264-022-01271-3] [Reference Citation Analysis]
3 Moza A, Bernad ES, Lungeanu D, Craina M, Bernad BC, Hogea L, Paul C, Muresan C, Nitu R, Iacob D. Pregnancy Outcomes in SARS-CoV-2-Positive Patients: A 20-Month Retrospective Analysis of Delivery Cases. Medicina (Kaunas) 2023;59. [PMID: 36837541 DOI: 10.3390/medicina59020341] [Reference Citation Analysis]
4 Jorgensen SCJ, Hernandez A, Fell DB, Austin PC, D'Souza R, Guttmann A, Brown KA, Buchan SA, Gubbay JB, Nasreen S, Schwartz KL, Tadrous M, Wilson K, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study. BMJ 2023;380:e074035. [PMID: 36754426 DOI: 10.1136/bmj-2022-074035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Fevery J, Dallmeier K. Immunologische aspecten van Covid-19-ziekte en van vaccinatie tegen SARS-CoV-2 Deel 1: SARS-CoV-2-immuunantwoord na infectie en vaccinatie. Tijdschr Geneesk 2022. [DOI: 10.47671/tvg.78.22.111] [Reference Citation Analysis]
6 Bosworth ML, Schofield R, Ayoubkhani D, Charlton L, Nafilyan V, Khunti K, Zaccardi F, Gillies C, Akbari A, Knight M, Wood R, Hardelid P, Zuccolo L, Harrison C. Vaccine effectiveness for preventing COVID-19 hospital admission during pregnancy: a population-based cohort study in England during the Alpha and Delta waves of the SARS-CoV-2 pandemic.. [DOI: 10.1101/2022.09.27.22280397] [Reference Citation Analysis]
7 . COVID-19 vaccination safe during pregnancy. Reactions Weekly 2022;1922:9-9. [DOI: 10.1007/s40278-022-22294-3] [Reference Citation Analysis]